228 related articles for article (PubMed ID: 9254084)
1. Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage.
Mathiesen T; Edner G; Ulfarsson E; Andersson B
J Neurosurg; 1997 Aug; 87(2):215-20. PubMed ID: 9254084
[TBL] [Abstract][Full Text] [Related]
2. Cytokine levels in cerebrospinal fluid and delayed ischemic deficits in patients with aneurysmal subarachnoid hemorrhage.
Kwon KY; Jeon BC
J Korean Med Sci; 2001 Dec; 16(6):774-80. PubMed ID: 11748361
[TBL] [Abstract][Full Text] [Related]
3. Elevated IL-6 and TNF-α Levels in Cerebrospinal Fluid of Subarachnoid Hemorrhage Patients.
Wu W; Guan Y; Zhao G; Fu XJ; Guo TZ; Liu YT; Ren XL; Wang W; Liu HR; Li YQ
Mol Neurobiol; 2016 Jul; 53(5):3277-3285. PubMed ID: 26063595
[TBL] [Abstract][Full Text] [Related]
4. Ventricular cerebrospinal fluid and serum concentrations of sTNFR-I, IL-1ra, and IL-6 after aneurysmal subarachnoid hemorrhage.
Gruber A; Rössler K; Graninger W; Donner A; Illievich MU; Czech T
J Neurosurg Anesthesiol; 2000 Oct; 12(4):297-306. PubMed ID: 11147377
[TBL] [Abstract][Full Text] [Related]
5. Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study.
Galea J; Ogungbenro K; Hulme S; Patel H; Scarth S; Hoadley M; Illingworth K; McMahon CJ; Tzerakis N; King AT; Vail A; Hopkins SJ; Rothwell N; Tyrrell P
J Neurosurg; 2018 Feb; 128(2):515-523. PubMed ID: 28298024
[TBL] [Abstract][Full Text] [Related]
6. Early Dynamics of Interleukin-6 in Cerebrospinal Fluid after Aneurysmal Subarachnoid Hemorrhage.
Ďuriš K; Neuman E; Vybíhal V; Juráň V; Gottwaldová J; Kýr M; Vašků A; Smrčka M
J Neurol Surg A Cent Eur Neurosurg; 2018 Mar; 79(2):145-151. PubMed ID: 28869993
[TBL] [Abstract][Full Text] [Related]
7. The effects of beta-adrenoceptor antagonists on proinflammatory cytokine concentrations after subarachnoid hemorrhage in rats.
Kato H; Kawaguchi M; Inoue S; Hirai K; Furuya H
Anesth Analg; 2009 Jan; 108(1):288-95. PubMed ID: 19095864
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin.
Lanzrein AS; Johnston CM; Perry VH; Jobst KA; King EM; Smith AD
Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):215-27. PubMed ID: 9772027
[TBL] [Abstract][Full Text] [Related]
9. Combined therapeutic hypothermia and barbiturate coma reduces interleukin-6 in the cerebrospinal fluid after aneurysmal subarachnoid hemorrhage.
Muroi C; Frei K; El Beltagy M; Cesnulis E; Yonekawa Y; Keller E
J Neurosurg Anesthesiol; 2008 Jul; 20(3):193-8. PubMed ID: 18580350
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 4 (TLR4) is correlated with delayed cerebral ischemia (DCI) and poor prognosis in aneurysmal subarachnoid hemorrhage.
Ma C; Zhou W; Yan Z; Qu M; Bu X
J Neurol Sci; 2015 Dec; 359(1-2):67-71. PubMed ID: 26671088
[TBL] [Abstract][Full Text] [Related]
11. Early elevated levels of soluble triggering receptor expressed on myeloid cells-1 in subarachnoid hemorrhage patients.
Sun XG; Ma Q; Jing G; Wang L; Hao XD; Wang GQ
Neurol Sci; 2017 May; 38(5):873-877. PubMed ID: 28229304
[TBL] [Abstract][Full Text] [Related]
12. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
van Bommel EF; Hesse CJ; Jutte NH; Zietse R; Bruining HA; Weimar W
Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
[TBL] [Abstract][Full Text] [Related]
13. Levels of Interleukin-1β, Interleukin-18, and Tumor Necrosis Factor-α in Cerebrospinal Fluid of Aneurysmal Subarachnoid Hemorrhage Patients May Be Predictors of Early Brain Injury and Clinical Prognosis.
Lv SY; Wu Q; Liu JP; Shao J; Wen LL; Xue J; Zhang XS; Zhang QR; Zhang X
World Neurosurg; 2018 Mar; 111():e362-e373. PubMed ID: 29277532
[TBL] [Abstract][Full Text] [Related]
14. The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial.
Singh N; Hopkins SJ; Hulme S; Galea JP; Hoadley M; Vail A; Hutchinson PJ; Grainger S; Rothwell NJ; King AT; Tyrrell PJ
J Neuroinflammation; 2014 Jan; 11():1. PubMed ID: 24383930
[TBL] [Abstract][Full Text] [Related]
15. Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes.
Maneiro E; López-Armada MJ; Fernández-Sueiro JL; Lema B; Galdo F; Blanco FJ
J Rheumatol; 2001 Dec; 28(12):2692-9. PubMed ID: 11764219
[TBL] [Abstract][Full Text] [Related]
16. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract][Full Text] [Related]
17. High-mobility group box 1 protein in CSF of patients with subarachnoid hemorrhage.
Nakahara T; Tsuruta R; Kaneko T; Yamashita S; Fujita M; Kasaoka S; Hashiguchi T; Suzuki M; Maruyama I; Maekawa T
Neurocrit Care; 2009 Dec; 11(3):362-8. PubMed ID: 19777384
[TBL] [Abstract][Full Text] [Related]
18. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
Gormley SM; McBride WT; Armstrong MA; McClean E; MacGowan SW; Campalani G; McMurray TJ
Cytokine; 2002 Jan; 17(2):61-5. PubMed ID: 11886172
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic modelling of interleukin-1 receptor antagonist in plasma and cerebrospinal fluid of patients following subarachnoid haemorrhage.
Gueorguieva I; Clark SR; McMahon CJ; Scarth S; Rothwell NJ; Tyrrell PJ; Hopkins SJ; Rowland M
Br J Clin Pharmacol; 2008 Mar; 65(3):317-25. PubMed ID: 17875190
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns.
Endo S; Inada K; Yamada Y; Kasai T; Takakuwa T; Nakae H; Kamei Y; Shimamura T; Suzuki T; Taniguchi S; Yoshida M
J Med; 1996; 27(1-2):57-71. PubMed ID: 8863178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
